A neurochemical basis for the antipsychotic activity of loxapine: Interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes

Journal of Psychiatry and Neuroscience

Volumn 21, Issue 1, 1996, Pages 29-35

  Singh, A N ^a,b   Barlas, C ^c   Singh, S ^c   Franks, P ^d   Mishra, R K ^c  

^a Hamilton Psychiatric Hospital   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Lederle (Cyanamid Canada Inc)   (Canada)

Author keywords

dopamine receptor; loxapine; serotonin receptor; typical and atypical neuroleptic

Indexed keywords

CLOZAPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; LOXAPINE; NEUROLEPTIC AGENT; SEROTONIN 2 RECEPTOR;

AGRANULOCYTOSIS; ARTICLE; BRAIN CORTEX; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HUMAN TISSUE; NEUROCHEMISTRY; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; TARDIVE DYSKINESIA;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BINDING SITES; CEREBRAL CORTEX; CULTURE TECHNIQUES; HUMANS; LOXAPINE; RECEPTORS, DOPAMINE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SEROTONIN;

EID: 0030067033     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Baldessarini RJ, Tarsy D. 1980. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Ann Rev Neurosci 3:23-42.
2. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylechararc EJ, Richardson BP, Saxena PR. 1986. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharm 25:563-576.
3. 2 receptor mRNA are up-regulated by antipsychotic drugs. Neurosci Lett 150:25-28.
4. Burki HR, Sayers AC, Ruch W, Asper H. 1977. Effects of clozapine and other dibenzoepines on central dopaminergic and cholinergic systems. Drug Res 27:1561-1565.
5. Burt DR, Cresse I, Snyder SM. 1977. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326-328.
6. Carlyle W, Ancill RJ, Sheldon L. 1993. Aggression in the demented patient: a study of loxapine versus haloperidol. Inter Clin Psychopharm 8:103-108.
7. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
8. Chesselet MF. 1984. Presynaptic regulation of neurotransmitter release in the brain. Neurosci 12:347-375.
9. 3H-spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated derivatives. Eur J Pharmacol 55:215-218.
10. Delini-Stula A. 1986. Neuroanatomical, neuropharmalogical and neurobiochemical target systems of antipsychotic activity of neuroleptics. Pharmacopsychiatry 19:134-139.
11. DePaulo JR, Ayd FJ. 1982. Loxapine: fifteen years' clinical experience. Psyschosomatics 23:261-267.
12. 2 dopamine receptor isoforms generated via alternative mRNA splicing. Eur J Pharmacol 183:1619-1628.
13. Hoyer D, Clarke DE, Fozard R, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PA. 1994. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
14. Kazmi SMI, Mishra RK. 1987. Comparative pharmacological properties and functional coupling of μ and δ opioid receptor sites in human neuroblastoma SH-SY5Y cells. Mol Pharmacol 32:109-118.
15. Lee T, Tang SW. 1984. Loxapine and clozapine decrease serotonin but do not elevate dopamine receptor numbers in rat brain. Psychiatry Res 12:277-285.
16. 2 receptor density in rat cerebral cortex. Life Sciences 45:1397-1406.
17. i values. J Pharmacol Exp Ther 251:238-246.
18. Saudou F, Hen R. 1994. 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates. Neurochem Int 25:503-532.
19. Sayers AC, Burki HR, Ruch W, Asper H. 1975. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Psychopharmacologia (Bere) 41:97-104.
20. Sayers AC, Burki HR, Ruch W, Asper H. 1977. Animal models for tardive dyskinesia: effects of thioridazine. Pharmacopsych Neuro-psychopharmacol 10:291-295.
21. Schwartz JT, Brotman AW. 1992. A clinical guide to antipsychotic drugs. Drugs 44:981-992.
22. Seeman MV. 1981. Pharmacological features and effects of neuroleptics. Can Med Assoc J 125:821-826.
23. Seeman P. 1980. Brain dopamine receptors. Pharmacol Rev 32:229-245.